Gisbert-Gustemps, Laura http://orcid.org/0000-0002-8329-1717
Lugo-Marín, Jorge
Ramos, Imanol Setien
Martín, Gemma Español
Vieta, Eduard
Bonnín, C. Mar
Quiroga, Josep Antoni Ramos
Funding for this research was provided by:
Instituto de Salud Carlos III (PI18/01788)
PERIS (SLT006/17/00287)
Article History
Received: 6 December 2020
Accepted: 8 June 2021
First Online: 29 June 2021
Declarations
:
: The study was approved by the Barcelona Universitari Vall d’Hebron Hospital’s Ethics Committee and was carried out in compliance with the Helsinki Declaration of 1975 (the evaluation, support, and prevention unit). Written informed consent was obtained from all participants.
: Not applicable.
: The author LGG received travel awards for taking part in psychiatric meetings from Shire in the last 3 years.The author EV has received grants and served as consultant, advisor or CME speaker for the following entities (unrelated to the present work): AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, and Takeda.The author JA.R.Q was on the speakers’ bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogui, Lundbeck, Almirall, Braingaze, Sincrolab, Medice and Rubió in the last 5 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire, Takeda, Shionogui, Bial, Medice and Eli- Lilly. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 5 years: Eli-Lilly, Lundbeck, Janssen- Cilag, Actelion, Shire, Ferrer, Oryzon, Roche, Psious, and Rubió.The authors JLM, ISR, GEM and CMB declare no conflict of interest.